Downgrades Buy Neutral X

IQV IQVIA

BTIG Research

Initiated Overweight X

IQV IQVIA

Stephens

$250

Initiated Buy X

IQV IQVIA

Redburn Atlantic

Initiated Outperform X

IQV IQVIA

RBC Capital Mkts

$275

Downgrades Buy Hold X

IQV IQVIA

Jefferies

$266 $242

Initiated Buy X

IQV IQVIA

Goldman

$270

Initiated Outperform X

IQV IQVIA

Leerink Partners

$290

Downgrades Buy Neutral X

IQV IQVIA

Guggenheim

Initiated Buy X

IQV IQVIA

BTIG Research

$285

Downgrades Outperform Neutral X

IQV IQVIA

Robert W. Baird

$248 $202

Initiated Buy X

IQV IQVIA

HSBC Securities

$260

Initiated Buy X

IQV IQVIA

Truist

$265

Initiated Outperform X

IQV IQVIA

Cowen

$251

Downgrades Buy Neutral X

IQV IQVIA

Citigroup

$275 $245

Initiated Outperform X

IQV IQVIA

Credit Suisse

$300

Initiated Outperform X

IQV IQVIA

SVB Leerink

$256

Initiated Buy X

IQV IQVIA

Guggenheim

$244

Upgrades Neutral Overweight X

IQV IQVIA

Piper Sandler

$231 $255

Downgrades Overweight Eq Weight X

IQV IQVIA

Wells Fargo

$235

Upgrades Eq-Weight Overweight X

IQV IQVIA

Stephens

$180 $250

Upgrades Sec Weight Overweight X

IQV IQVIA

KeyBanc Capital Markets

$218

Initiated Overweight X

IQV IQVIA

Barclays

$220

Upgrades Neutral Buy X

IQV IQVIA

Mizuho

$150 $175

Initiated Outperform X

IQV IQVIA

SVB Leerink

Upgrades Hold Buy X

IQV IQVIA

Jefferies

Initiated Buy X

IQV IQVIA

UBS

Reiterated Outperform X

IQV IQVIA

Robert W. Baird

$143 $146

Upgrades Neutral Buy X

IQV IQVIA

BofA/Merrill

Reiterated Buy X

IQV IQVIA

Stifel

$128 $150

Upgrades Outperform Strong Buy X

IQV IQVIA

Raymond James

Upgrades Neutral Buy X

IQV IQVIA

Goldman

Upgrades Hold Buy X

IQV IQVIA

SunTrust

IQV  IQVIA Holdings Inc.

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.